Elotuzumab Intravenous and Propranolol Sustained-Release Capsules
Determining the interaction of Elotuzumab Intravenous and Propranolol Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: elotuzumab
Brand name: Empliciti
Synonyms: Elotuzumab
Generic Name: propranolol
Brand name: Hemangeol, Inderal LA, Inderal XL, InnoPran XL, Inderal, InnoPran XL
Synonyms: Propranolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elotuzumab Intravenous-Propranolol Tablets
- Elotuzumab Intravenous-Proprinal
- Elotuzumab Intravenous-Propulsid
- Elotuzumab Intravenous-Propulsid (Cisapride Suspension)
- Elotuzumab Intravenous-Propulsid (Cisapride Tablets)
- Elotuzumab Intravenous-Propylhexedrine
- Propranolol Sustained-Release Capsules-Eloxatin
- Propranolol Sustained-Release Capsules-Elppa CoQ10 coenzyme Q-10
- Propranolol Sustained-Release Capsules-Elspar
- Propranolol Sustained-Release Capsules-Elta SilverGel
- Propranolol Sustained-Release Capsules-Elta Tar
- Propranolol Sustained-Release Capsules-Eltrombopag